Nasus Pharma LTD (NSRX) — 20-F Filings
All 20-F filings from Nasus Pharma LTD. Browse 1 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (1)
-
Nasus Pharma Faces Going Concern Doubt Amidst Clinical Development Push
— Mar 25, 2026 Risk: high
Nasus Pharma Ltd. (NSRX) is a clinical-stage specialty pharmaceutical company focused on intranasal drugs for emergency medical conditions. The company has not
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX